Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-14-001185
Filing Date
2014-08-18
Accepted
2014-08-18 16:22:41
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA INC. 10Q 2014-06-30 signpath.htm 10-Q 828184
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh311.htm EX-31.1 15432
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh321.htm EX-32.1 7711
  Complete submission text file 0001096906-14-001185.txt   5312652

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT sppxbrl-20140630.xml EX-101.INS 1128791
5 XBRL SCHEMA DOCUMENT sppxbrl-20140630.xsd EX-101.SCH 32980
6 XBRL CALCULATION LINKBASE DOCUMENT sppxbrl-20140630_cal.xml EX-101.CAL 14100
7 XBRL DEFINITION LINKBASE DOCUMENT sppxbrl-20140630_def.xml EX-101.DEF 45286
8 XBRL LABELS LINKBASE DOCUMENT sppxbrl-20140630_lab.xml EX-101.LAB 130909
9 XBRL PRESENTATION LINKBASE DOCUMENT sppxbrl-20140630_pre.xml EX-101.PRE 113510
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 141049245
SIC: 2834 Pharmaceutical Preparations